Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights

Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...

Related Keywords

Walloon Region ,Waals Gewest ,Belgium ,Parc ,Region Flamande ,Boston ,Massachusetts ,United States ,London ,City Of ,United Kingdom ,Mont Saint Guibert ,American ,David Georges ,Georges Rawadi ,Caroline Lonez ,International Conference On Lymphocyte Engineering ,Dartmouth College ,Wrd Communications ,Society For Immunotherapy Of Cancer ,Company Or Celyad Oncology ,World Oncology Cell Therapy Congress ,Exchange Commission ,Business Development ,Celdara Medical ,Business Development Intellectual Property ,Chief Executive Officer ,Celyad Oncology ,Chief Executive ,Vice President Business Development ,Intellectual Property ,American Depositary Shares ,Nasdaq Global ,Euronext Brussels ,Lancet Haematology Journal ,Immuno Oncology Summit Europe ,Axis Parc ,International Conference ,Lymphocyte Engineering ,San Diego ,Belgium Fixed ,Belgium Mobile ,Private Securities Litigation Reform Act ,Annual Report ,Consolidated Statement ,Comprehensive Income ,Financial Position ,Markets ,